Risk factor
Very poor trading liquidity
Profitability factor
Weak growth
About
TMC Life Sciences Berhad operates as an investment holding entity, specializing in the provision of healthcare services throughout Malaysia. Its primary asset is Thomson Hospital Kota Damansara (THKD), a substantial 559-bed medical facility located in Selangor. THKD delivers a comprehensive spectrum of medical specialties, including orthopedics, ear, nose, and throat (ENT) care, head and neck laser procedures, dedicated services for women and children, fertility treatments, dietetic guidance, and emergency care. The company's fertility centers offer advanced reproductive technologies such as time-lapse imaging, preimplantation genetic testing, and fertility genecode analysis, alongside expert consultancy services. Beyond its main hospital operations, TMC Life Sciences manages a network of women's clinics and fertility centers, provides laboratory and embryology services, traditional and complementary medicine, and operates pharmacy outlets. Its activities further extend to developing and marketing healthcare programs, offering multi-disciplinary tertiary care support, engaging in research and development initiatives, and undertaking property investments. Established in 1994 and based in Petaling Jaya, Malaysia, the company is a subsidiary of Sasteria (M) Pte. Ltd.
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITDA